健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XLV 健康照护类股ETF-SPDR

休市中 06-05 16:00:00 EDT

153.01

+0.93

+0.61%

盘后153.10

+0.09+0.06%

19:56 EDT

最高154.70	最低152.92	成交量2,072万
今开153.38	昨收152.08	日振幅1.17%
总市值390.05亿	流通市值390.05亿	总股本2.55亿
成交额31.85亿	换手率8.13%	流通股本2.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"健康照护类股ETF-SPDR","latestPrice":153.01,"timestamp":1780689600000,"preClose":152.08,"halted":0,"volume":20722948,"hourTrading":{"tag":"盘后","latestPrice":153.1,"preClose":153.01,"latestTime":"19:56 EDT","volume":52219,"amount":7977335.2008,"timestamp":1780703794193,"change":0.09,"changeRate":0.000588,"amplitude":0.009999},"delay":0,"changeRate":0.006115202524986706,"floatShares":254915324,"shares":254915324,"eps":-14.217021,"marketStatus":"休市中","change":0.93,"latestTime":"06-05 16:00:00 EDT","open":153.38,"high":154.7,"low":152.92,"amount":3184901381.7113204,"amplitude":0.011704,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":152.08,"sharesOutstanding":267365324,"nav":153.004728,"aum":38942047911.24,"dividendRate":0.016394,"bidAskSpread":0.000079,"preHourTrading":{"tag":"盘前","latestPrice":153.34,"preClose":152.08,"latestTime":"09:29 EDT","volume":17839,"amount":2723554.16185,"timestamp":1780666199999,"change":1.26,"changeRate":0.008285,"amplitude":0.00868},"postHourTrading":{"tag":"盘后","latestPrice":153.1,"preClose":153.01,"latestTime":"19:56 EDT","volume":52219,"amount":7977335.2008,"timestamp":1780703794193,"change":0.09,"changeRate":0.000588,"amplitude":0.009999},"volumeRatio":1.679478772925177,"optionData":{"bulkOrders":[{"symbol":"XLV","call":true,"expireDate":1799989200000,"strike":"152.0","timestamp":1780668333297,"price":10.05,"volume":30000,"amount":30150000,"type":"-"},{"symbol":"XLV","call":true,"expireDate":1799989200000,"strike":"157.0","timestamp":1780668333297,"price":7.85,"volume":10000,"amount":7850000,"type":"-"}]},"impliedVol":0.2451,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/XLV","defaultTab":"news","newsList":[{"id":"1149997054","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1149997054","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149997054?lang=zh_cn&edition=full","pubTime":"2026-06-06 00:26","pubTimestamp":1780676796,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态发布。美东时间凌晨2点06分 - 伯恩斯坦分析师在一份研究报告中指出，阿斯利康在其核心肿瘤业务之外发布的管线药物数据前景乐观，但市场似乎低估了其价值。Bell Potter表示，这一差距反映了过去几个月，在市场等待EBR启动融资期间，其股价的急剧下跌。EBR Systems股价下跌11%，报0.39澳元。（本文已进行更正，以反映EBR Systems计划以每股0.38澳元筹集1.08亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641161560","title":"欧洲股市反弹 医疗保健板块领涨 渣打和汇丰等英国银行股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161560","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641161560?lang=zh_cn&edition=full","pubTime":"2026-06-05 01:42","pubTimestamp":1780594920,"startTime":"0","endTime":"0","summary":"欧洲股市周四反弹，医疗保健股上涨，Abivax SA和Zealand Pharma A/S涨幅居前。　　斯托克欧洲600指数收盘上涨0.5%，摆脱早盘跌势。医疗保健、金融服务和零售板块领涨，矿业股和电信股表现最差。　　Abivax大涨18%，此前该股因一项关键临床试验中的癌症病例而暴跌。　　欧洲股市今年以来上涨逾5%，但仍落后于美国和亚洲市场的涨势，后两者对AI主题的敞口更大。这导致瑞银集团的一篮子AI赢家股票下跌1.6%，不过该篮子今年以来仍上涨逾40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-05/doc-iniahnxk9041101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0149534421.HKD","IEFA","LU1267930227.SGD","FEZ","BK4534","LU0496365809.HKD","BK1619","VEA","XBI","LU0310800965.SGD","BK4207","STAN.UK","BK1601","FLEE","SG9999001689.USD","LU0976567544.SGD","BK4550","HSBC","LU0211326755.USD","03143","BK4588","02888","LU0052756011.USD","VGK","EURL","LU0211326839.USD","EPV","XLV","LU0211977185.USD","SG9999000327.SGD","VHT","LU0607220059.USD","BK4581","HSBH","IEUR","BK4504","LABU","LU0128525689.USD","LU2236285917.USD","SPEU","IEV","BK1572","BK1231","BK4585","BK4521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120703317","title":"医疗保健板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1120703317","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120703317?lang=zh_cn&edition=full","pubTime":"2026-06-04 00:22","pubTimestamp":1780503772,"startTime":"0","endTime":"0","summary":"0548 ET - AJ Bell的Russ Mould指出，诺和诺德在阿联酋推出其口服减肥药Wegovy是一个重要的里程碑，这标志着该公司首次在美国以外地区推出其肥胖治疗药物的口服版本。Mould称，这一点在美国市场已得到印证，口服剂型于今年初推出后，需求一直很健康。诺和诺德的主要竞争对手礼来公司已于四月宣布在阿联酋推出其自身的口服减肥药。诺和诺德股价上涨0.1%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","XLV","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196937471","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1196937471","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196937471?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:26","pubTimestamp":1780475203,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康板块的市场对话。他表示，明年公司员工将可以免费使用GLP-1药物，因为他相信这将有助于降低公司的整体医疗成本。分析师表示，负责监督和有权管辖跨地区诉讼的法官小组已将集体诉讼移交至北加州联邦法院，由法官Vince Chhabria审理。该法官在最近的听证会上对该和解方案持负面看法，并在2020年驳回了拜耳解决Roundup诉讼的尝试。拜耳股价下跌5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4585","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111791195","title":"医疗健康板块市场动态汇总","url":"https://stock-news.laohu8.com/highlight/detail?id=1111791195","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111791195?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:53","pubTimestamp":1780433606,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康领域的市场对话。他指出，服用这些减肥药的人正在购买更多浆果以确保获得足够的营养。他本人正推动 Driscoll's 为员工报销更多GLP-1类药物费用，并称明年将为员工免费提供这类药物，因为他认为这将降低公司的整体医疗成本。拜耳股价下跌5%。Paragon Care的盈利预警使其失去了一位看涨者。Bell Potter指出，Paragon Care此前9700万至1.07亿澳元的指引未包含Haju Medical。Bell Potter将Paragon Care的评级从买入下调至持有，并将其目标价大幅下调逾40%，至每股0.17澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4588","BK4585","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198010928","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1198010928","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198010928?lang=zh_cn&edition=full","pubTime":"2026-06-03 00:24","pubTimestamp":1780417443,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态发布。分析师们就行业关键事件展开热议。该股股价下跌31%。Paragon Care的盈利预警使其失去了一位看涨者。Paragon Care目前预计2026财年收入为37亿澳元，息税折旧摊销前利润在9500万至1亿澳元之间。Bell Potter指出，Paragon Care此前给出的9700万至1.07亿澳元的指引未包含Haju Medical。他将2026财年和2027财年的每股收益预测分别下调了10%和18%。Bell Potter将Paragon Care的评级从买入下调至持有，并将其目标价大幅下调逾40%，至每股0.17澳元。Paragon Care周一收于每股0.16澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LABU","XLV","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182826648","title":"医疗健康板块综述：市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1182826648","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182826648?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:29","pubTimestamp":1780302564,"startTime":"0","endTime":"0","summary":"医疗健康板块最新市场动态一览。然而，公司的核心业务依然稳健，目前其价值被低估且受到忽视。该公司股价下跌0.4%，报174.45欧元。这家印度公司正将其在国内资本效率高的店中店模式及公私合营模式复制到海外市场。上午5点42分——在加拿大皇家银行资本市场看来，Pro Medicus新合同的期限被视为好消息。加拿大皇家银行给予该股与大市同步评级，目标价为195.00澳元。该股上涨8.1%，报142.95澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588","XLV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639607386","title":"国家医保局发布2026年国家医保目录调整工作方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2639607386","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639607386?lang=zh_cn&edition=full","pubTime":"2026-05-31 10:19","pubTimestamp":1780193940,"startTime":"0","endTime":"0","summary":"自2027年开始，截止日期将确定为方案发布之日","market":"sh","thumbnail":"https://img3.gelonghui.com/f3af3-4ae020e2-682d-46bb-8d75-0673a1077883.jpg?guru_height=3384&guru_width=4608&guru_size=1145570","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/f3af3-4ae020e2-682d-46bb-8d75-0673a1077883.jpg?guru_height=3384&guru_width=4608&guru_size=1145570"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4990180","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4588","XBI","BK4585","LABU","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639960204","title":"国家医保局发布2026年国家医保目录调整工作方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2639960204","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639960204?lang=zh_cn&edition=full","pubTime":"2026-05-31 09:20","pubTimestamp":1780190400,"startTime":"0","endTime":"0","summary":"据央视新闻消息，国家医保局今天发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整申报指南》《谈判药品续约规则》以及《非独家药品竞价规则》。同时，为帮助社会各界加深对政策的理解，组织编制了《国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整常用问答》。","market":"sh","thumbnail":"https://media.bjnews.com.cn/cover/2024/12/23/5535172268222656082.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2024/12/23/5535172268222656082.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1780190346129721.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1780190346129721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["XBI","BK4581","XLV","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648130","title":"金元顺安医疗健康混合A基金经理变动：增聘韩辰尧为基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648130","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639648130?lang=zh_cn&edition=full","pubTime":"2026-05-29 09:53","pubTimestamp":1780019637,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年5月29日，金元顺安医疗健康混合发布公告，增聘韩辰尧为基金经理，任职日期自2026年5月29日起，陈铭杰不再担任该基金基金经理，离任日期为2026年5月29日，变更后金元顺安医疗健康混合的基金经理为张海东,韩辰尧。2022年05月加入金元顺安基金管理有限公司。2023年3月1日任金元顺安成长动力灵活配置混合型证券投资基金、金元顺安价值增长混合型证券投资基金基金经理。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/29/20260529636636.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/29/20260529636636.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260529/32263775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["XBI","BK4581","XLV","BK4588","VHT","IXJ","159760","BK4585","LABU","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638353496","title":"Labcorp将出席Jefferies全球医疗保健大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638353496","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638353496?lang=zh_cn&edition=full","pubTime":"2026-05-28 04:00","pubTimestamp":1779912036,"startTime":"0","endTime":"0","summary":"全球领先的综合实验室服务提供商Labcorp Holdings Inc．今日宣布，公司将出席2026年Jefferies全球医疗保健大会并发表演讲。会议将于6月3日在纽约举行，公司演讲定于美国东部时间下午12时15分开始。　　Labcorp是一家业务覆盖约100个国家、拥有近71，000名员工的全球实验室服务巨头，为全球患者每年进行数亿次检测。　　根据公司2026年第一季度财报，Labcorp业绩表现强劲。　　本次会议演讲将通过网络直播，投资者可通过Labcorp投资者关系网站访问。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-28/doc-inhzksma8866144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4588","BK4581","LABU","XBI","BK4550","BK4585","VHT","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638638727","title":"AngioDynamics将出席高盛第47届全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638638727","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638638727?lang=zh_cn&edition=full","pubTime":"2026-05-28 03:02","pubTimestamp":1779908523,"startTime":"0","endTime":"0","summary":"医疗技术公司AngioDynamics今日宣布，公司管理团队将出席高盛第47届全球医疗保健年会并发表演讲。会议将于2026年6月10日举行，公司演讲定于美国东部时间上午9时20分开始。　　AngioDynamics是一家专注于恢复人体血管系统健康血流、拓展癌症治疗方案并改善患者生活质量的变革性医疗技术公司。其中医疗技术业务净销售额为3730万美元，同比增长19.0%，Auryon销售额增长17.9%，血栓管理业务增长17.9%，NanoKnife销售额增长21.0%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-28/doc-inhzknce0518623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["GS","BK4533","IE00B19Z3B42.SGD","LU1668664300.SGD","LU0106831901.USD","LU0742534661.SGD","VHT","XBI","LU1868837300.USD","LU2237443382.USD","BK4581","LU2237443465.HKD","LU1868836757.USD","LU2471134952.CNY","LU0345770308.USD","IE00BSNM7G36.USD","GSX","IE00B19Z3581.USD","LABU","LU0061475181.USD","LU0345770993.USD","LU0942090050.USD","LU2237443978.SGD","LU0096364046.USD","XLV","BK4588","BK4552","BK4504","LU2237438978.USD","LU1868836591.USD","LU2237443549.SGD","LU1868837136.USD","LU2471134796.USD","LU1894683348.USD","IE0002270589.USD","LU1894683264.USD","BK4585","BK4550","LU1868836914.USD","LU2237443895.HKD","LU0868494617.USD","LU2750360641.GBP","LU0048573561.USD","BK4516","LU2471134879.HKD","IE00BFXG1179.USD","LU0251142724.SGD","IE0034235188.USD","LU0251131958.USD","LU1791807156.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183915257","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1183915257","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183915257?lang=zh_cn&edition=full","pubTime":"2026-05-28 00:22","pubTimestamp":1779898974,"startTime":"0","endTime":"0","summary":"医疗保健领域的最新市场对话。新西兰时间21时37分：费雪派克医疗凭借其运营杠杆效应和不断变化的临床实践，继续成为麦格理银行的首选标的之一。麦格理将费雪派克在新西兰上市股票的目标价下调4.6%，至43.70新西兰元。该股目前上涨1.6%，报37.30新西兰元。Ryman股价上涨2.7%，至2.28新西兰元。在其调查的GLP-1药物使用者中，61%的受访者减少了热量摄入，37%的人减少了外出就餐频率，约半数人转向食用更健康的食品。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638681039","title":"核心III期数据进入倒计时，Vistagen将出席Jefferies全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638681039","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638681039?lang=zh_cn&edition=full","pubTime":"2026-05-27 23:28","pubTimestamp":1779895680,"startTime":"0","endTime":"0","summary":"专注于开发新型鼻内给药神经科学药物的Vistagen宣布，公司将出席于2026年6月2日至4日在纽约举行的Jefferies全球医疗保健年会。会议期间，公司管理层将与机构投资者进行一对一交流，介绍其创新的pherine候选药物管线的最新进展。　　Vistagen的先导候选药物fasedienol正处于美国注册导向的III期临床开发阶段，用于社交焦虑症的急性治疗。Vistagen认为，若其中任何一项III期试验成功，连同PALISADE-2的积极结果，可能构成提交新药上市申请所需的有效性实质证据。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-27/doc-inhzkfve8244142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["III","LABU","VHT","BK4581","BK4585","BK4588","XBI","BK4134","BK4550","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638896436","title":"临床阶段RNAi疗法公司Silence Therapeutics将出席Jefferies全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638896436","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638896436?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:37","pubTimestamp":1779892620,"startTime":"0","endTime":"0","summary":"临床阶段RNAi疗法公司Silence Therapeutics近日宣布，公司管理层将出席2026年6月3日下午4：55举行的Jefferies全球医疗保健年会，并进行分析师主导的炉边谈话。投资者可通过公司官网投资者关系页面收听现场网络直播，回放将在会议结束后提供。　　Silence Therapeutics目前最受关注的资产是divesiran，一种靶向TMPRSS6的siRNA疗法，用于治疗真性红细胞增多症。　　Silence Therapeutics总部位于伦敦，在纳斯达克以“SLN”代码交易，员工约88人。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-27/doc-inhzkfvc1451718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4539","VHT","BK4550","BK4007","LENZ","XBI","XLV","BK4585","BK4588","LABU","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638968964","title":"临床阶段肿瘤生物技术公司Immunome将出席高盛第47届全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638968964","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638968964?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:31","pubTimestamp":1779892260,"startTime":"0","endTime":"0","summary":"临床阶段肿瘤生物技术公司Immunome5月27日宣布，公司管理层将出席2026年6月9日举行的高盛第47届全球医疗保健年会，并进行公司演讲。演讲定于当日上午10：40进行。投资者可通过公司官网投资者关系页面收听现场网络直播，并在直播结束后约30天内回看会议重播。　　Immunome目前最受关注的核心资产是varegacestat，一种正在研究的γ分泌酶抑制剂，用于治疗成人硬纤维瘤。　　截至2026年3月31日，Immunome持有现金及现金等价物约5.827亿美元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-27/doc-inhzkfvh9050122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1868836757.USD","LU2471134952.CNY","GSX","LU2237443622.USD","LU1868837136.USD","BK4552","LU1868836591.USD","IE00B19Z3581.USD","BK4588","LU0868494708.USD","LU2750360997.AUD","IE00B19Z3B42.SGD","BK4550","LU1804176565.USD","LU1894683348.USD","LU1668664300.SGD","LU2237443465.HKD","IE00BSNM7G36.USD","BK4533","LU2237443382.USD","BK4127","LU0061475181.USD","IE0002270589.USD","VHT","LU0742534661.SGD","LU2471134796.USD","LU0106831901.USD","LU2237438978.USD","BK4516","LABU","BK4585","LU0096364046.USD","LU2471134523.USD","BK4504","XLV","LU1894683264.USD","LU2237443549.SGD","LU0868494617.USD","LU1868836914.USD","IE0004086264.USD","XBI","LU2265009873.SGD","LU0251142724.SGD","LU2237443978.SGD","LU0251131958.USD","LU2237443895.HKD","LU2471134879.HKD","LU0345770308.USD","LU0048573561.USD","IE0004091025.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198005255","title":"医疗保健板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1198005255","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198005255?lang=zh_cn&edition=full","pubTime":"2026-05-27 16:23","pubTimestamp":1779870221,"startTime":"0","endTime":"0","summary":"最新医疗保健板块市场动态速览。麦格理分析师认为，医疗设备制造商费雪派克医疗凭借其运营杠杆效应及不断演变的临床实践，仍位列该投行的首选股名单。麦格理将费雪派克医疗新西兰上市股票的目标价下调4.6%，至43.70新西兰元。该股目前上涨1.6%，报37.30新西兰元。麦格理认为，退休社区运营商莱曼医疗保健设定的到2029财年释放5亿新西兰元现金的目标显得保守。Vane-Tempest表示：“市场对该公司结构性增长驱动因素和近期逆风的敞口给予了合理的回报。”","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4581","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638545982","title":"DocGo将出席高盛第47届全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638545982","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638545982?lang=zh_cn&edition=full","pubTime":"2026-05-26 23:07","pubTimestamp":1779808020,"startTime":"0","endTime":"0","summary":"移动医疗及医疗运输服务提供商DocGo Inc．今日宣布，公司首席执行官李·比恩斯托克将出席高盛第47届全球医疗保健年会，并参与炉边谈话。本次活动将通过DocGO官网投资者关系频道提供网络直播。　　DocGo是一家领先的移动医疗服务商，通过其创新的移动医疗平台、远程患者监测、救护车服务及覆盖全美50州的虚拟护理网络，重塑传统的实体医疗系统。　　此外，DocGo于今年3月启动的战略选择评估仍在进行中，公司将适时披露最新进展。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-26/doc-inhzfwqh8894225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0868494617.USD","VHT","IE0004091025.USD","LU0942090050.USD","IE00BFXG1179.USD","LU1804176565.USD","LU1668664300.SGD","LABU","LU0106831901.USD","LU1868836591.USD","BK4533","GSX","BK4504","IE0034235188.USD","LU1868836757.USD","BK4581","BK4588","LU2237443382.USD","LU2471134879.HKD","LU1868837136.USD","XBI","LU0345770993.USD","LU2750360641.GBP","XLV","LU0096364046.USD","LU2750360997.AUD","LU2237443978.SGD","LU2237443895.HKD","IE00BSNM7G36.USD","LU0251142724.SGD","LU0868494708.USD","BK4516","LU0061475181.USD","IE00B19Z3581.USD","LU2237438978.USD","LU0251131958.USD","IE00B19Z3B42.SGD","IE0004086264.USD","LU2471134523.USD","LU2237443622.USD","LU1894683348.USD","LU0048573561.USD","BK4552","IE0002270589.USD","LU0345770308.USD","GS","LU2471134952.CNY","LU2237443465.HKD","LU2471134796.USD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638596533","title":"高广伟获批担任和谐健康董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2638596533","media":"金融一线","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638596533?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:23","pubTimestamp":1779693780,"startTime":"0","endTime":"0","summary":"5月25日金融一线消息，四川金融监管局发布《关于高广伟和谐健康保险股份有限公司董事任职资格的批复》，核准高广伟和谐健康保险股份有限公司董事的任职资格。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：曹睿潼","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/hm/2026-05-25/doc-inhzawmk2586037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","XLV","BK4588","LABU","SINA","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184748314","title":"医疗健康板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1184748314","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184748314?lang=zh_cn&edition=full","pubTime":"2026-05-23 16:22","pubTimestamp":1779524572,"startTime":"0","endTime":"0","summary":"最新一期医疗健康板块市场动态聚焦。默克股价上涨4%。Recordati股价下跌0.3%，而CVC和GBL的股价均上涨约1%。该分析师指出，这家比利时投资者将投入13亿欧元，这在其5亿至15亿欧元的投资范围内，但处于较高水平。荷兰国际集团表示，此次收购也表明GBL对医疗健康领域兴趣浓厚，该集团已涉足医疗服务和医疗技术领域。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4588","XLV","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://us.spdrs.com/etf/health-care-select-sector-spdr-fund-XLV","stockEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":0.0523},{"period":"3month","weight":0.002},{"period":"6month","weight":-0.0016},{"period":"1year","weight":0.1495},{"period":"ytd","weight":-0.0116}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"本基金追踪标普健康板块指数(S&P Health Care Select Sector index)，并将95%以上的资产投资在该指数包含的成分股，其中包含了医疗保健、生物科技、制药相关的公司。\n风险提示：标的成分和权重，有可能随着时间的迁移而发生变化。","yearOnYearQuotes":[{"month":1,"riseRate":0.607143,"avgChangeRate":0.009527},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.002019},{"month":3,"riseRate":0.571429,"avgChangeRate":0.0058},{"month":4,"riseRate":0.535714,"avgChangeRate":0.012982},{"month":5,"riseRate":0.678571,"avgChangeRate":0.005168},{"month":6,"riseRate":0.535714,"avgChangeRate":0.003549},{"month":7,"riseRate":0.62963,"avgChangeRate":0.011509},{"month":8,"riseRate":0.555556,"avgChangeRate":0.001611},{"month":9,"riseRate":0.37037,"avgChangeRate":-0.015959},{"month":10,"riseRate":0.592593,"avgChangeRate":0.007405},{"month":11,"riseRate":0.777778,"avgChangeRate":0.02456},{"month":12,"riseRate":0.666667,"avgChangeRate":0.010581}],"exchange":"ARCA","name":"健康照护类股ETF-SPDR","nameEN":"Health Care Select Sector SPDR Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健康照护类股ETF-SPDR,XLV,健康照护类股ETF-SPDR股票,健康照护类股ETF-SPDR股票老虎,健康照护类股ETF-SPDR股票老虎国际,健康照护类股ETF-SPDR行情,健康照护类股ETF-SPDR股票行情,健康照护类股ETF-SPDR股价,健康照护类股ETF-SPDR股市,健康照护类股ETF-SPDR股票价格,健康照护类股ETF-SPDR股票交易,健康照护类股ETF-SPDR股票购买,健康照护类股ETF-SPDR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}